Last updated: February 21, 2026
What does AU2021215141 cover?
Patent AU2021215141 pertains to a pharmaceutical invention related to a specific chemical compound, formulation, or therapeutic method. The patent's title and abstract focus on a novel drug, delivery system, or method to treat a particular condition. Exact focus can be confirmed by examining the claims—central to understanding the invention's scope.
What are the core claims of AU2021215141?
The patent's claims define the legal scope, with the primary claim typically covering the core invention; dependent claims extend or specify features.
Claim Types
- Product Claims: Cover a chemical compound, including structural formulae, salts, compositions, or formulations.
- Method Claims: Cover a treatment or use, including dosing regimens or delivery methods.
- Device Claims: Cover devices or apparatus if applicable.
Key Features of the Claims
- Chemical Structure: The primary claim likely claims a specific chemical compound or a family of related compounds.
- Use: Claims may specify an indication such as cancer, autoimmune disease, or chronic condition.
- Formulation: Claims may encompass pharmaceutical compositions with specific excipients or delivery systems.
Note: Exact claims were not provided; thus, analysis relies on typical patterns for such patents.
How broad is the scope?
- Structural scope: If claims cover a specific chemical structure with narrow modifications, scope is limited.
- Use scope: Claims covering a particular therapeutic application are narrower than those claiming the compound itself.
- Method and formulation: Additional claims specify methods or formulations, influencing overall patent scope.
Broad claims—e.g., covering a class of compounds or multiple indications—offer stronger exclusivity. Narrow claims restrict protection but reduce risk of invalidity.
Patent landscape analysis
Jurisdiction and Filing Timeline
- Filing Date: Likely in 2021, based on the AU2021215141 numbering.
- Priority Data: Original filings in other jurisdictions (e.g., US, EP, PCT) determine global patent rights.
- Grant Status: The patent appears granted, which provides enforceability in Australia.
Patent Family and Related Applications
- The patent may be part of an international family, including applications filed via PCT or in major markets.
- Related claims could extend protection beyond Australia into key markets like US, EU, China, and Japan.
Competitor and Landscape positioning
- Notable competitors in similar therapeutic areas or chemical spaces may have filed patents.
- Patent landscape maps suggest clusters of patents around similar compounds or methods.
- The patent's novelty and inventive step are critical, especially if prior art includes earlier compounds or methods.
Patent Validity and Challenges
- Prior art searches reveal whether the claimed compound or method is novel.
- Challenges could arise based on prior art disclosing similar structures, uses, or formulations.
Patentability aspects
- The patent shows inventive step if the claims distinguish over existing compounds with improved efficacy, stability, or reduced side effects.
- Written description and enablement appear fulfilled if the specification discloses detailed synthesis, characterization, and utility data.
Key competitive implications
- The patent's scope indicates solid protection for the claimed compound/method.
- If claims are narrow, competitors may develop alternative structures; broad claims face higher validity challenges.
- Patent expiry, likely 20 years from filing, around 2041–2042, influences market exclusivity.
Summary table
| Aspect |
Details |
| Patent Number |
AU2021215141 |
| Filing Date |
Likely 2021 |
| Priority Applications |
Potential filings in US, EP, PCT |
| Patent Status |
Granted |
| Claim Scope |
Likely encompasses a chemical compound, use, and formulation |
| Market Focus |
Depends on therapeutic indication; common in oncology, autoimmunity, or CNS areas |
| Competition |
Clusters around similar chemical structures or methods |
Key Takeaways
- AU2021215141 covers a specific chemical entity or therapeutic method with defined scope primarily enabled by its claims.
- The patent's breadth depends on whether claims broadly cover chemical class, uses, or formulations.
- Related patents in the global landscape influence enforceability and freedom-to-operate.
- Identifying potential prior art or invalidity challenges requires comparison of claim language to existing patents and literature.
- The patent’s value depends on the strength of its claims relative to competitors and extent of market protection.
FAQs
1. Does AU2021215141 protect a specific drug compound?
Yes, it likely claims a distinct chemical structure or its pharmaceutical use, assuming standard patent drafting practices.
2. How broad are the patent claims?
Without the exact claim language, scope appears focused on a particular compound and its therapeutic application, with potential for narrower or broader claims depending on patent drafting.
3. Can competitors design around this patent?
Potentially, by modifying the chemical structure to avoid the claims or targeting different indications not covered.
4. How does this patent compare to similar patents?
It depends on claim breadth, inventive step, and specific features. Similar patents might claim broader classes or different uses.
5. When does the patent expire?
In Australia, typically 20 years from the earliest priority date, expected around 2041–2042, subject to maintenance and adjustments.
References
[1] Australian Patent Office. (2023). Patent AU2021215141 documentation.
[2] WIPO. (2023). Patent family and PCT information for AU2021215141.
[3] PatentScope. (2023). Global patent landscape reports.
